Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Dalcetrapib reduces risk of new-onset diabetes in patients with coronary heart diseaseSchwartz, G.G.; Leiter, L.A.; Ballantyne, C.M.; Barter, P.J.; Black, D.M.; Kallend, D.; Laghrissi-Thode, F.; Leitersdorf, E.; McMurray, J.J.V.; Nicholls, S.J.; Olsson, A.G.; Preiss, D.; Shah, P.K.; Tardif, J.-C.; Kittelson, J.
2023Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialGray, M.P.; Berman, Y.; Bottà, G.; Grieve, S.M.; Ho, A.; Hu, J.; Hyun, K.; Ingles, J.; Jennings, G.; Kilov, G.; Levesque, J.F.; Meikle, P.; Redfern, J.; Usherwood, T.; Vernon, S.T.; Nicholls, S.J.; Figtree, G.A.
2022Immunoglobulin E sensitization to mammalian oligosaccharide galactose-α-1,3 (α-Gal) is associated with noncalcified plaque, obstructive coronary artery disease, and ST-segment-elevated myocardial infarctionVernon, S.T.; Kott, K.A.; Hansen, T.; Finemore, M.; Baumgart, K.W.; Bhindi, R.; Yang, J.; Hansen, P.S.; Nicholls, S.J.; Celermajer, D.S.; Ward, M.R.; van Nunen, S.A.; Grieve, S.M.; Figtree, G.A.
2022Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocolMarschner, S.; Wing-Lun, E.; Chow, C.; Maple-Brown, L.; Graham, S.; Nicholls, S.J.; Brown, A.; Wood, A.; Ihdayhid, A.; Von Huben, A.; Zaman, S.